Torthaí cuardaigh - Hong Jae Chon

Beachtaigh na torthaí
  1. 1
    Current perspectives and future strategies of chemotherapy for pancreatic cancer: a narrative review

    Current perspectives and future strategies of chemotherapy for pancreatic cancer: a narrative review de réir Hong Jae Chon

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors

    Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors de réir Ho Jung An, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors

    Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors de réir Chang‐Myung Oh, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Epidemiology and genomic features of biliary tract cancer and its unique features in Korea

    Epidemiology and genomic features of biliary tract cancer and its unique features in Korea de réir Seonjeong Woo, Youngun Kim, Sohyun Hwang, Hong Jae Chon

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

    Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity de réir Won Suk Lee, Hannah Yang, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach

    Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach de réir Chang-Gon Kim, Yun Beom Sang, Ji Hyun Lee, Hong Jae Chon

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer

    Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer de réir Chan Kim, Hong Jae Chon, Beodeul Kang, Ki‐Yeol Kim, Hei‐Cheul Jeung, Hyun Cheol Chung, Sung Hoon Noh, Sun Young Rha

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients

    Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients de réir Sun Min Lim, Youn Nam Kim, Ki Hyun Park, Beodeul Kang, Hong Jae Chon, Chan Kim, Joo Hoon Kim, Sun Young Rha

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

    Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study de réir Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Young Eun Chon, Hong Jae Chon

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

    Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment de réir Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do young Kim, Seong Gyu Hwang, Hong Jae Chon, Beom Kyung Kim

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy

    Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy de réir Eun-Jin Go, Hannah Yang, Hong Jae Chon, Da Som Yang, WonHyoung Ryu, Dong‐Hyun Kim, Dong Keun Han, Chan Kim, Wooram Park

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

    Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma de réir Jaekyung Cheon, Hyeyeong Kim, Han Sang Kim, Chang Gon Kim, Il Hwan Kim, Beodeul Kang, Chan Kim, Sanghoon Jung, Yeonjung Ha, Hong Jae Chon

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Treatment Outcomes of Sunitinib Treatment in Advanced Renal Cell Carcinoma Patients: A Single Cancer Center Experience in Korea

    Treatment Outcomes of Sunitinib Treatment in Advanced Renal Cell Carcinoma Patients: A Single Cancer Center Experience in Korea de réir Min Hee Hong, Hyo Song Kim, Chan Kim, Jung Ryun Ahn, Hong Jae Chon, Sang Joon Shin, Joong Bae Ahn, Hyun Cheol Chung, Sun Young Rha

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade

    STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade de réir Hannah Yang, Won Suk Lee, So Jung Kong, Chang Gon Kim, Joo Hoon Kim, Sei Kyung Chang, Sewha Kim, Gwangil Kim, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma

    Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma de réir Chan Kim, Hannah Yang, Il Hwan Kim, Beodeul Kang, Hyeyeong Kim, Hyunho Kim, Won Suk Lee, Sanghoon Jung, Ho Yeong Lim, Jaekyung Cheon, Hong Jae Chon

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

    Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis de réir Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, Neung Hwa Park, Jung Woo Shin, Kang Mo Kim, Han Chu Lee, Joo‐Ho Lee, Changhoon Yoo, Baek‐Yeol Ryoo

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    STING signaling is a potential immunotherapeutic target in colorectal cancer

    STING signaling is a potential immunotherapeutic target in colorectal cancer de réir Hong Jae Chon, Hyojoong Kim, Jung Hyun Noh, Hannah Yang, Won Suk Lee, So Jung Kong, Seung‐Jun Lee, Yu Seong Lee, Woo Ram Kim, Joo Hang Kim, Gwangil Kim, Chan Kim

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer

    Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer de réir Yu Seong Lee, Won Suk Lee, Chang Woo Kim, Seung Joon Lee, Hannah Yang, So Jung Kong, John Ning, Kyung-Mee Yang, Beodeul Kang, Woo Ram Kim, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

    STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer de réir Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma

    Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma de réir Hong Jae Chon, Woo Jin Hyung, Chan Kim, Sohee Park, Jie‐Hyun Kim, Chan Hyuk Park, Joong Bae Ahn, Hyunki Kim, Hyun Cheol Chung, Sun Young Rha, Sung Hoon Noh, Hei‐Cheul Jeung

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: